Vanguard FTSE 100 UCITS ETF (LON:VUKG)
London · Delayed Price · Currency is GBP | Assets | 2.01B |
| Expense Ratio | 0.09% |
| PE Ratio | 17.76 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | Quarterly |
| Payout Ratio | 61.02% |
| 1-Year Return | +20.76% |
| Volume | 90,587 |
| Open | 55.47 |
| Previous Close | 55.45 |
| Day's Range | 55.19 - 55.61 |
| 52-Week Low | 45.16 |
| 52-Week High | 57.79 |
| Beta | 0.98 |
| Holdings | 103 |
| Inception Date | May 14, 2019 |
About VUKG
Vanguard FTSE 100 UCITS ETF is an exchange traded fund launched by Vanguard Group (Ireland) Limited. It is co-managed by Vanguard Asset Management, Limited and The Vanguard Group, Inc. The fund invests in the public equity markets of the United Kingdom. It seeks to invest in the stocks of companies operating across diversified sectors. The fund invests in the stocks of large-cap companies. It seeks to replicate the performance of the FTSE 100 Index, by investing in the stocks of companies as per their weightings in the index. The fund was formerly known as Vanguard Funds Public Limited Company - Vanguard FTSE 100 ETF. Vanguard FTSE 100 UCITS ETF was formed on May 22, 2012 and is domiciled in Ireland.
Performance
VUKG had a total return of 20.76% in the past year, including dividends. Since the fund's inception, the average annual return has been 8.97%.
Top 10 Holdings
49.19% of assets| Name | Symbol | Weight |
|---|---|---|
| HSBC Holdings plc | HSBA | 9.59% |
| AstraZeneca PLC | AZN | 8.29% |
| Shell plc | SHEL | 7.11% |
| Rolls-Royce Holdings plc | RR | 4.55% |
| British American Tobacco p.l.c. | BATS | 3.87% |
| Unilever PLC | ULVR | 3.62% |
| Rio Tinto Group | RIO | 3.30% |
| BP p.l.c. | BP | 3.28% |
| GSK plc | GSK | 3.01% |
| Barclays PLC | BARC | 2.55% |